$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

$bnet Overview Financials Valuation SEC Filings Company Website

2020 Q3 Form 10-K Financial Statement

#000107997320000805 Filed on September 22, 2020

Income Statement

Concept	2020 Q3	2020	2019 Q2
Revenue			$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$302.9K	$3.090M	$452.1K
YoY Change	-5.42%	79.15%	73.87%
% of Gross Profit
Research & Development	$90.99K	$1.124M	$132.6K
YoY Change	-26.22%	372.64%	121.07%
% of Gross Profit
Depreciation & Amortization	$207.00	$1.248K	$340.00
YoY Change	-40.35%	79.83%
% of Gross Profit
Operating Expenses	$394.1K	$4.215M	$585.0K
YoY Change	-11.23%	345.43%	82.83%
Operating Profit		-$4.215M
YoY Change		345.43%
Interest Expense	-$104.3K	$466.9K	-$123.0K
YoY Change	-188.72%	79.34%	53.73%
% of Operating Profit
Other Income/Expense, Net		-$338.5K	$0.00
YoY Change		30.01%
Pretax Income	-$498.4K	-$4.553M	-$708.0K
YoY Change	-11.24%	71.23%	183.21%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$498.4K	-$4.553M	-$707.3K
YoY Change	-11.24%	71.24%	182.91%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$16.17K	-$156.6K	-$25.99K
COMMON SHARES
Basic Shares Outstanding	30.82M
Diluted Shares Outstanding	30.79M	29.03M

Balance Sheet

Concept	2020 Q3	2020	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$336.1K	$560.8K	$41.34K
YoY Change	350.37%	1256.63%	106.7%
Cash & Equivalents	$336.1K		$41.34K
Short-Term Investments
Other Short-Term Assets	$17.90K	$8.970K	$9.010K
YoY Change	39.52%	-0.44%	-9.9%
Inventory
Prepaid Expenses	$16.90K		$8.005K
Receivables
Other Receivables			$1.000K
Total Short-Term Assets	$354.0K	$569.8K	$50.34K
YoY Change	304.76%	1031.88%	65.12%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.161K	$1.370K	$2.616K
YoY Change	-48.83%	-47.71%	80.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.161K	$1.370K	$2.616K
YoY Change	-48.83%	-47.71%	80.66%
TOTAL ASSETS
Total Short-Term Assets	$354.0K	$569.8K	$50.34K
Total Long-Term Assets	$1.161K	$1.370K	$2.616K
Total Assets	$355.2K	$571.2K	$52.96K
YoY Change	295.82%	978.47%	65.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$648.7K	$628.9K	$715.6K
YoY Change	-17.9%	-12.11%	-0.62%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due	$9.678M	$9.601M	$9.303M
YoY Change	3.24%	3.2%	3.03%
Total Short-Term Liabilities	$11.21M	$11.04M	$10.93M
YoY Change	-0.87%	1.07%	7.1%
LONG-TERM LIABILITIES
Long-Term Debt	$4.646M	$4.616M	$3.801M
YoY Change	20.7%	21.43%	7.68%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$4.646M	$4.616M	$3.801M
YoY Change	20.7%	21.43%	7.68%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.21M	$11.04M	$10.93M
Total Long-Term Liabilities	$4.646M	$4.616M	$3.801M
Total Liabilities	$15.86M	$15.70M	$14.73M
YoY Change	4.61%	6.25%	7.29%
SHAREHOLDERS EQUITY
Retained Earnings	-$129.4M		-$124.3M
YoY Change	3.59%		2.18%
Common Stock	$0.00		$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$15.54M	-$15.13M	-$14.72M
YoY Change
Total Liabilities & Shareholders Equity	$355.2K	$571.2K	$52.96K
YoY Change	295.82%	978.47%	65.82%

Cashflow Statement

Concept	2020 Q3	2020	2019 Q2
OPERATING ACTIVITIES
Net Income	-$498.4K	-$4.553M	-$707.3K
YoY Change	-11.24%	71.24%	182.91%
Depreciation, Depletion And Amortization	$207.00	$1.248K	$340.00
YoY Change	-40.35%	79.83%
Cash From Operating Activities	-$247.2K	-$966.4K	-$201.8K
YoY Change	63.54%	19.15%	124.26%
INVESTING ACTIVITIES
Capital Expenditures			$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities			$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	22.50K	1.486M	93.99K
YoY Change	-87.8%	78.4%	34.27%
NET CHANGE
Cash From Operating Activities	-247.2K	-966.4K	-201.8K
Cash From Investing Activities			0.000
Cash From Financing Activities	22.50K	1.486M	93.99K
Net Change In Cash	-224.7K	519.5K	-107.8K
YoY Change	-774.98%	2588.61%	439.2%
FREE CASH FLOW
Cash From Operating Activities	-$247.2K	-$966.4K	-$201.8K
Capital Expenditures			$0.00
Free Cash Flow	-$247.2K	-$966.4K	-$201.8K
YoY Change		18.78%	124.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	18655000
CY2020	bnet	Deferred Compensation Consecutive Trading Days DeferredCompensationConsecutiveTradingDays	P10D
CY2020	bnet	Deferred Compensation Conversion Days DeferredCompensationConversionDays	P5D
CY2018	bnet	Deferred Compensation Liability Amount Cancelled DeferredCompensationLiabilityAmountCancelled	2404000
CY2020Q2	bnet	Deferred Tax Assets Business Interest DeferredTaxAssetsBusinessInterest	217000
CY2019Q2	bnet	Deferred Tax Assets Business Interest DeferredTaxAssetsBusinessInterest
CY2020	bnet	Defined Contribution Pension And Other Postretirement Plans Minimum Age DefinedContributionPensionAndOtherPostretirementPlansMinimumAge	P21Y
CY2019	bnet	Adjustment To Additional Paid In Capital Modification Of Warrants AdjustmentToAdditionalPaidInCapitalModificationOfWarrants	188493
CY2020	bnet	Adjustment To Additional Paid In Capital Modification Of Warrants AdjustmentToAdditionalPaidInCapitalModificationOfWarrants	1558015
CY2019	bnet	Adjustment To Additional Paid In Capital Modification Ofoptions AdjustmentToAdditionalPaidInCapitalModificationOfoptions	222300
CY2020	bnet	Adjustment To Additional Paid In Capital Modification Ofoptions AdjustmentToAdditionalPaidInCapitalModificationOfoptions	626058
CY2020	bnet	Common Stock Voting Rights Votes Per Share CommonStockVotingRightsVotesPerShare	1
CY2020Q2	bnet	Computers And Office Equipment Gross ComputersAndOfficeEquipmentGross	171485
CY2019Q2	bnet	Computers And Office Equipment Gross ComputersAndOfficeEquipmentGross	173245
CY2020	bnet	Conversion Of Debt And Liabilities ConversionOfDebtAndLiabilities	71658
CY2019	bnet	Conversion Of Debt And Liabilities ConversionOfDebtAndLiabilities	100000
CY2020	bnet	Conversion Of Deferred Compensation Into Note Payable Affiliate ConversionOfDeferredCompensationIntoNotePayableAffiliate	636081
CY2019	bnet	Conversion Of Deferred Compensation Into Note Payable Affiliate ConversionOfDeferredCompensationIntoNotePayableAffiliate	150000
CY2020	bnet	Effective Income Tax Rate Reconciliation Expiration Of Net Operating Allowance Amount EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingAllowanceAmount	71000
CY2019	bnet	Effective Income Tax Rate Reconciliation Expiration Of Net Operating Allowance Amount EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingAllowanceAmount	850000
CY2020	bnet	Effective Income Tax Rate Reconciliation Rtp Excess Business Interest Amount EffectiveIncomeTaxRateReconciliationRTPExcessBusinessInterestAmount	-103000
CY2019	bnet	Effective Income Tax Rate Reconciliation Rtp Excess Business Interest Amount EffectiveIncomeTaxRateReconciliationRTPExcessBusinessInterestAmount
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013Q2	bnet	Extension Of Exercise Period Annual Payment Per Option Or Warrant ExtensionOfExercisePeriodAnnualPaymentPerOptionOrWarrant	0.05
CY2020	bnet	Gain Loss On Extinguishment Of Liabilities GainLossOnExtinguishmentOfLiabilities	122423
CY2019	bnet	Gain Loss On Extinguishment Of Liabilities GainLossOnExtinguishmentOfLiabilities
CY2020	bnet	Income Tax Reconciliation Permanent Differences IncomeTaxReconciliationPermanentDifferences	9000
CY2019	bnet	Income Tax Reconciliation Permanent Differences IncomeTaxReconciliationPermanentDifferences	2000
CY2020Q2	bnet	Interest Rate On Deferred Compensation InterestRateOnDeferredCompensation	0.04
CY2020Q2	bnet	Loans Payable Current Including Accrued Interest And Late Charges LoansPayableCurrentIncludingAccruedInterestAndLateCharges	9585883
CY2019Q2	bnet	Loans Payable Current Including Accrued Interest And Late Charges LoansPayableCurrentIncludingAccruedInterestAndLateCharges	9303270
CY2020	bnet	Loans Payable To Affiliates LoansPayableToAffiliates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">4.</div>     LOANS PAYABLE - AFFILIATES:</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">During the year ended <div style="display: inline; font-style: italic; font: inherit;"> June 30, 2020, </div>Dominic Bassani (“Bassani”), the Company's Chief Executive Officer, and Mark A. Smith (“Smith”), the Company's President, loaned the Company <div style="display: inline; font-style: italic; font: inherit;">$20,000</div> and <div style="display: inline; font-style: italic; font: inherit;">$15,000,</div> respectively, for working capital needs. The loans were non-interest bearing and Bassani's loan was repaid in cash, while Smith's loan was converted into units of the Company at <div style="display: inline; font-style: italic; font: inherit;">$0.50</div> per unit, with each unit consisting of <div style="display: inline; font-style: italic; font: inherit;">one</div> share of the Company's restricted common stock and <div style="display: inline; font-style: italic; font: inherit;">one</div> warrant to purchase <div style="display: inline; font-style: italic; font: inherit;">one</div> share of the Company's restricted common stock for <div style="display: inline; font-style: italic; font: inherit;">$0.75</div> per share until <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2022.</div></div></div>
CY2020	bnet	Proceeds From The Sale Of Units ProceedsFromTheSaleOfUnits	1584000
CY2019	bnet	Proceeds From The Sale Of Units ProceedsFromTheSaleOfUnits	896801
CY2019	bnet	Sale Of Units Value SaleOfUnitsValue	896801
CY2020	bnet	Sale Of Units Value SaleOfUnitsValue	1584000
CY2020Q2	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	704309
CY2019Q2	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	704309
CY2020	bnet	Shares Issued For Accounts Payable And Accrued Expenses SharesIssuedForAccountsPayableAndAccruedExpenses	6750
CY2019	bnet	Shares Issued For Accounts Payable And Accrued Expenses SharesIssuedForAccountsPayableAndAccruedExpenses
CY2018	bnet	Shares Issued For Warrant Exercise Commissions SharesIssuedForWarrantExerciseCommissions	514
CY2020	bnet	Shares Issued For Warrant Exercise Commissions SharesIssuedForWarrantExerciseCommissions
CY2019	bnet	Shares Issued For Warrant Exercise Commissions SharesIssuedForWarrantExerciseCommissions	514
CY2019	bnet	Stock Issued During Period Shares Commissions On Sale Of Units StockIssuedDuringPeriodSharesCommissionsOnSaleOfUnits	1028
CY2019	bnet	Stock Issued During Period Value Commissions On Sale Of Units StockIssuedDuringPeriodValueCommissionsOnSaleOfUnits	63880
CY2020	bnet	Stock Issued During Period Value Commissions On Sale Of Units StockIssuedDuringPeriodValueCommissionsOnSaleOfUnits	147900
CY2020	bnet	Warrants Issued For Unit Commissions WarrantsIssuedForUnitCommissions	16509
CY2019	bnet	Warrants Issued For Unit Commissions WarrantsIssuedForUnitCommissions	4850
CY2020	bnet	Warrants Subscribed But Unissued Subscriptions Receivable WarrantsSubscribedButUnissuedSubscriptionsReceivable
CY2019	bnet	Warrants Subscribed But Unissued Subscriptions Receivable WarrantsSubscribedButUnissuedSubscriptionsReceivable	330000
CY2020	bnet	Weighted Average Exercise Price For Outstanding Warrants WeightedAverageExercisePriceForOutstandingWarrants	0.73
CY2020	bnet	Weighted Average Number Of Shares Issued During Period WeightedAverageNumberOfSharesIssuedDuringPeriod	1666727
CY2019	bnet	Weighted Average Number Of Shares Issued During Period WeightedAverageNumberOfSharesIssuedDuringPeriod	1286743
CY2020	bnet	Weighted Average Remaining Contractual Life For Outstanding Warrants WeightedAverageRemainingContractualLifeForOutstandingWarrants	P3Y219D
CY2020Q2	bnet	Working Capital WorkingCapital	-10474000
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Security12g Title Security12gTitle	Common Stock, No Par Value
CY2020Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	628926
CY2019Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	715554
CY2020Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2794257
CY2019Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2794769
CY2020Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	114266683
CY2019Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	110126802
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	236100
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	429200
CY2019	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	6250
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2500
CY2020Q2	us-gaap	Assets Assets	571161
CY2019Q2	us-gaap	Assets Assets	52956
CY2020Q2	us-gaap	Assets Current AssetsCurrent	569793
CY2019Q2	us-gaap	Assets Current AssetsCurrent	50340
CY2020Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	401470
CY2019Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	401470
CY2020Q2	us-gaap	Cash Cash	560828
CY2019Q2	us-gaap	Cash Cash	41335
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-06-30
CY2020	dei	Document Type DocumentType	10-K
CY2020Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30821347
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019Q4	dei	Entity Public Float EntityPublicFloat	9400000
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	41335
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22013
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	560828
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	519493
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	19322
CY2020Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	20400000
CY2020Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2019Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2020Q2	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	504650
CY2019Q2	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	504650
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31409005
CY2019Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28068688
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25939892
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30704696
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27364379
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25235583
CY2020Q2	us-gaap	Common Stock Value CommonStockValue
CY2019Q2	us-gaap	Common Stock Value CommonStockValue
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Concentrations of credit risk:</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company's financial instruments that are exposed to concentrations of credit risk consist of cash. The Company's cash is in demand deposit accounts placed with federally insured financial institutions and selected brokerage accounts. Such deposit accounts at times <div style="display: inline; font-style: italic; font: inherit;"> may </div>exceed federally insured limits. The Company has <div style="display: inline; font-style: italic; font: inherit;">not</div> experienced any losses on such accounts.</div></div></div></div></div></div></div></div></div></div>
CY2009Q1	us-gaap	Construction Loan ConstructionLoan	7750000
CY2020Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	4595841
CY2019Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	3801168
CY2020Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	778217
CY2019Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	874162
CY2020Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	19799000
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4545735
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2654202
CY2020Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2019Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2020Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11975000
CY2019Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11864000
CY2020Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1340000
CY2019Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1340000
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	1194000
CY2019Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	1027000
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5073000
CY2019Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4244000
CY2020Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	19799000
CY2019Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18655000
CY2020Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1000
CY2019Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1000
CY2020	us-gaap	Depreciation Depreciation	1248
CY2019	us-gaap	Depreciation Depreciation	1314
CY2020	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
CY2019	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.16
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1
CY2020Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3089689
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1724677
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1144000
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-198000
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-955000
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-557000
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-166000
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-97000
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	95376
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	8858
CY2020	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	520525
CY2019	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	668600
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-40
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	531
CY2020	us-gaap	Interest Expense InterestExpense	466891
CY2019	us-gaap	Interest Expense InterestExpense	413057
CY2020	us-gaap	Interest Paid Net InterestPaidNet
CY2019	us-gaap	Interest Paid Net InterestPaidNet
CY2020Q2	us-gaap	Liabilities Liabilities	15659119
CY2019Q2	us-gaap	Liabilities Liabilities	14727554
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	571161
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52956
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	11043359
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	10926386
CY2020Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	2222670
CY2019Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	2222670
CY2020Q2	us-gaap	Minority Interest MinorityInterest	41902
CY2019Q2	us-gaap	Minority Interest MinorityInterest	49408
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1485900
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	832921
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2482
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-966407
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-811117
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-7506
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4930
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-338468
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-413057
CY2020	us-gaap	Operating Expenses OperatingExpenses	4214773
CY2019	us-gaap	Operating Expenses OperatingExpenses	2246075
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-4214773
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-2246075
CY2020Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	48564000
CY2020	us-gaap	Other Noncash Expense OtherNoncashExpense	502934
CY2019	us-gaap	Other Noncash Expense OtherNoncashExpense	448690
CY2020	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	6000
CY2019	us-gaap	Other Nonoperating Income OtherNonoperatingIncome
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	147900
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	63880
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2482
CY2020Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7965
CY2019Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	8005
CY2020	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	34800
CY2019	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt
CY2020	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1584000
CY2019	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	897000
CY2020	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	35000
CY2019	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt
CY2020	us-gaap	Profit Loss ProfitLoss	-4553241
CY2019	us-gaap	Profit Loss ProfitLoss	-2659132
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.74
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2020Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2795625
CY2019Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2797385
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1368
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2616
CY2020	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	20000
CY2019	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1123836
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	520084
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-128891893
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-124346158
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.26
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	2589134
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	721084
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	9511600
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.74
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	70625
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	110000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	655000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2210000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.19
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	20375
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6827225
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7411600
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9511600
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.11
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.08
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.69
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.74
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.72
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y182D
CY2019Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
CY2019Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2020Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y292D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y36D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y182D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	429200
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	236100
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	2210000
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.19
CY2020Q2	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Current SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent	35400
CY2019Q2	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Current SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent	33400
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised
CY2019	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	100000
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	71658
CY2019	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	93408
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	16350
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-15129860
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	-14724006
CY2018Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-13694938
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14674598
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15087958
CY2020Q2	us-gaap	Unsecured Debt Current UnsecuredDebtCurrent	14933
CY2019Q2	us-gaap	Unsecured Debt Current UnsecuredDebtCurrent
CY2020Q2	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	19919
CY2019Q2	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Use of estimates:</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In preparing the Company's consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div></div></div></div></div></div>
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29031106
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26522326
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	29031106
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	26522326

Files In Submission

Name	View Source	Status
0001079973-20-000805-index-headers.html	Edgar Link	pending
0001079973-20-000805-index.html	Edgar Link	pending
0001079973-20-000805.txt	Edgar Link	pending
0001079973-20-000805-xbrl.zip	Edgar Link	pending
bion_10k-063020.htm	Edgar Link	pending
bion_ex31z1.htm	Edgar Link	pending
bion_ex31z2.htm	Edgar Link	pending
bion_ex32z1.htm	Edgar Link	pending
bion_ex32z2.htm	Edgar Link	pending
bnet-20200630.xml	Edgar Link	completed
bnet-20200630.xsd	Edgar Link	pending
bnet-20200630_cal.xml	Edgar Link	unprocessable
bnet-20200630_def.xml	Edgar Link	unprocessable
bnet-20200630_lab.xml	Edgar Link	unprocessable
bnet-20200630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

2020 Q3 Form 10-K Financial Statement

#000107997320000805 Filed on September 22, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNET BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

2020 Q3 Form 10-K Financial Statement

#000107997320000805 Filed on September 22, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet